Mc Ilrath & Eck, LLC Pfizer Inc Transaction History

Mc Ilrath & Eck, LLC

$574 Million
Q3 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 6,294 shares of PFE stock, worth $165,909. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,294

Previous 7,107 11.44%

Holding current value

$165,909

Previous $198,000 8.08%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 19, 2024	SELL	$27.7 - $31.39 $22,520 - $25,520	-813 Reduced 11.44%	6,294 $182,000
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $2,627 - $3,078	104 Added 1.49%	7,107 $198,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $9,165 - $10,524	-354 Reduced 4.81%	7,003 $194,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $9,380 - $12,184	-359 Reduced 4.65%	7,357 $211,000
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $19,286 - $22,543	-601 Reduced 7.23%	7,716 $255,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $34,855 - $40,327	-965 Reduced 10.4%	8,317 $305,000
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $46,913 - $61,074	1,191 Added 14.72%	9,282 $378,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $22,962 - $29,975	550 Added 7.29%	8,091 $414,000
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $11,858 - $14,476	-271 Reduced 3.47%	7,541 $330,000
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $35,269 - $41,818	758 Added 10.75%	7,812 $410,000
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $45 - $56	1 Added 0.01%	7,054 $365,000
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $21,321 - $31,605	-516 Reduced 6.82%	7,053 $416,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $2,315 - $2,974	59 Added 0.79%	7,569 $326,000
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $7,289 - $8,258	-203 Reduced 2.63%	7,510 $294,000
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $6,262 - $7,062	-187 Reduced 2.37%	7,713 $279,000
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $57,501 - $73,118	1,718 Added 27.79%	7,900 $291,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $42,513 - $49,877	1,339 Added 27.65%	6,182 $227,000
Q2 2020 Aug 04, 2020	BUY	$30.12 - $36.54 $30,692 - $37,234	1,019 Added 26.65%	4,843 $158,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $3,000 - $4,286	-111 Reduced 2.82%	3,824 $125,000
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $13,991 - $15,878	425 Added 12.11%	3,935 $154,000
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $14,263 - $18,495	-439 Reduced 11.12%	3,510 $126,000
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $37,612 - $41,323	1,003 Added 34.05%	3,949 $168,000
Q4 2018 May 07, 2019	BUY	$38.47 - $43.86 $6,847 - $7,807	178 Added 6.43%	2,946 $129,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $12,719 - $15,427	369 Added 15.38%	2,768 $122,000
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $1,055 - $1,125	32 Added 1.35%	2,399 $87,000
Q1 2018 May 22, 2018	SELL	$31.91 - $37.02 $90,720 - $105,247	-2,843 Reduced 54.57%	2,367 $84,000
Q4 2017 Mar 19, 2018	BUY	$33.26 - $35.29 $173,284 - $183,860	5,210	5,210 $189,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account